DCE prevented the changes in the gene expression of GSR, PGC-1α and NOX-4 (p < 0.05 for all) induced by obesity and also increased the mRNA levels of GPX-3 (p < 0.05). The gene discussed is PPARGC1A; the disease is obesity due to melanocortin 4 receptor deficiency.